logo
The ancient ritual that could help improve your sleep

The ancient ritual that could help improve your sleep

Independent10-08-2025
An ancient ritual involving the forceful blowing of a conch shell could offer a surprising, non-invasive treatment for a widespread sleep disorder, according to new research.
Known as shankh blowing, the practice involves a deep inhalation followed by a powerful exhalation into the spiral-shaped shell of a sea snail.
Researchers suggest this technique could significantly improve sleep for individuals suffering from obstructive sleep apnoea (OSA), potentially negating the need for cumbersome medical equipment.
Obstructive sleep apnoea, which affects an estimated eight million people in the UK, occurs when the throat muscles relax and narrow during sleep, leading to symptoms such as loud snoring, choking noises, and frequent awakenings.
The findings stem from a small trial conducted in India, involving 30 participants aged between 19 and 65, all diagnosed with OSA.
For the trial, 16 people were provided with a traditional shankh used in yogic practices and trained in how to use it properly before taking it home, while the remaining 14 people were asked to carry out deep breathing exercises.
Both groups were encouraged to practice for a minimum of 15 minutes five days a week.
They were monitored during sleep and asked questions about sleep quality and how tired they felt during the day.
After six months, the study found those who practised shankh blowing reported sleeping better and were 34 per cent less sleepy during the day.
They also had higher levels of oxygen in the blood during the night and had four to five fewer apnoeas, where breathing stops during sleep, per hour on average.
They also had higher levels of oxygen in their blood during the night.
Dr Krishna K Sharma, of the Eternal Heart Care Centre and Research Institute in Jaipur, India, said: 'The way the shankh is blown is quite distinctive.
'It involves a deep inhalation followed by a forceful, sustained exhalation through tightly pursed lips.
'This action creates strong vibrations and airflow resistance, which likely strengthens the muscles of the upper airway, including the throat and soft palate, areas that often collapse during sleep in people with OSA.
'The shankh's unique spiralling structure may also contribute to specific acoustic and mechanical effects that further stimulate and tone these muscles.'
Continuous positive airway pressure (Cpap) machines are the first line of treatment for OSA.
They involve patients wearing a mask that blows pressurised air into the nose and throat while they sleep.
However, they can be uncomfortable.
Speaking of Cpap, Dr Sharma said: 'While effective, many patients find it uncomfortable and struggle to use it consistently.'
He suggests shankh blowing could be a 'promising alternative'.
'Shankh blowing is a simple low-cost, breathing technique that could help improve sleep and reduce symptoms without the need for machines or medication,' Dr Sharma said.
Researchers are now planning a larger trial involving several hospitals.
Dr Sharma added: 'This next phase will allow us to validate and expand on our findings in a broader, more diverse population and assess how shankh blowing performs over longer periods.
'We also want to study how this practice affects airway muscle tone, oxygen levels and sleep in greater detail.
'We're particularly interested in comparing shankh blowing with standard treatments like Cpap, and in examining its potential help in more severe forms of OSA.'
Reacting to the findings, Professor Sophia Schiza, head of the ERS group on sleep disordered breathing, based at the University of Crete, Greece, said: 'We know that OSA patients have poor quality of sleep, and higher risks of high blood pressure, strokes and heart disease.
'A proportion of patients experience sleepiness during the day.
'While Cpap and other treatments are available based on careful diagnosis of disease severity, there is still need for new treatments.
'This is an intriguing study that shows the ancient practice of shankh blowing could potentially offer an OSA treatment for selected patients by targeting muscles training.
'A larger study will help provide more evidence for this intervention which could be of benefit as a treatment option or in combination with other treatments in selected OSA patients.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Functional beverages' are booming — but is it all hype?
‘Functional beverages' are booming — but is it all hype?

Times

time5 hours ago

  • Times

‘Functional beverages' are booming — but is it all hype?

Before you take that magnesium supplement or sit down to meditate, what if a drink could help you relax? Enter 'functional beverages', drinks that claim to possess additional health benefits beyond those of a standard fizzy drink or fruit juice. Functional drinks are surging in popularity, with supermarkets in Britain seeing sales increase by 24.5 per cent in the past year, according to Worldpanel by Numerator. The market research firm also said that almost 30 per cent of UK households now purchase functional drinks. However, Nichola Ludlam-Raine, a dietician with more than 15 years of clinical experience in the NHS, has warned that she 'wouldn't rely on them [functional drinks] for measurable health benefits'. Ludlam-Raine, who now works privately and is the author of How Not to Eat Ultra-Processed , said: 'Functional drinks containing ingredients like CBD [cannabidiol], lion's mane [a type of mushroom], and ashwagandha [a herb typically used in ayurvedic medicine] are part of a growing wellness trend, but the science isn't as strong as the marketing.'

The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem
The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem

The Guardian

time6 hours ago

  • The Guardian

The Guardian view on regulating cosmetic procedures: rogue operators must be tackled, but aren't the only problem

The enormous popularity of beauty treatments, including dermatological fillers and Botox injections, is not solely an issue for health regulators. Changing norms and aspirations about appearances, and the way that these are marketed mainly to women and girls, are a cultural and economic phenomenon that requires wider consideration. While attitudes to these procedures and aesthetics vary, many people – including some cosmetic surgeons – are concerned that younger women account for a growing share of a highly lucrative and growing market. The death last year of 33-year-old Alice Webb in Gloucestershire, after a non-surgical Brazilian butt lift, as well as multiple reports of injuries, and the deaths of at least 28 women who have travelled to Turkey for cosmetic treatments, have increased the pressure on ministers to tighten the law. Wes Streeting's announcement of new licence requirements for UK businesses, and tighter regulation of higher-risk treatments, is probably overdue. The Chartered Trading Standards Institute recently warned that untrained people have given cosmetic injections in public toilets and hotels. Altering the law in order to exclude such 'rogue operators' ought to make high streets and the internet – where many clinics advertise – safer. Talking about the risks, as the health secretary has been doing, and holding a consultation on proposed changes, may have the beneficial effect of raising awareness even before changes are introduced. But councils will need resources if they are to be expected to enforce new rules by issuing licences, checking premises and so on. As in many other areas of economic activity, the law on its own is unlikely to be enough. Mechanisms are needed to ensure that businesses comply. It is already illegal to administer Botox or dermal fillers to children in England – although, worryingly, it is still allowed in Wales and Scotland. Mr Streeting's announcement that rules regarding children will be tightened further is particularly welcome. Strenuous efforts should be made to place them off limits for the industry as a whole. The reported preoccupation of some children with anti-ageing products is not healthy and should be discouraged. Mr Streeting did not refer to the cost to the NHS if cosmetic procedures go wrong, when announcing plans to tighten the law. But Karin Smyth, one of his ministers, has raised this. And Prof Sir Stephen Powis, who was NHS England's national medical director until last month, made the same point specifically in relation to butt lifts – the cosmetic procedure with the highest death rate of all. Ministers should expect pushback even though many experts, including plastic surgeons, favour tighter rules. The pro-growth mood of the Treasury means proposals for new regulations are unlikely to be smiled upon there. The more restrictive approach being proposed for England will also do nothing to prevent surgical tourism and could even increase it, if tighter regulation of the domestic industry results in higher prices. The gap in safeguards that allows foreign cosmetic surgery providers to market directly to the public needs to be addressed separately, which the government has begun to recognise. There is no single or instant fix. But by cracking down on cowboy operators, ministers will send a message that appearance-altering injections and other invasive treatments must be treated seriously. They are a different order of activity from applying makeup or painting nails. Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here.

Obese to get soups and shakes diet instead of weight-loss jabs
Obese to get soups and shakes diet instead of weight-loss jabs

Times

time7 hours ago

  • Times

Obese to get soups and shakes diet instead of weight-loss jabs

Low-calorie soups and shakes are to be prescribed to thousands of overweight people in Scotland in an attempt to reduce their dependence on expensive weight-loss drugs and provide longer-lasting health benefits. From January, 3,000 patients who have been newly diagnosed with type 2 diabetes will be recruited for a clinical trial. About 300,000 Scots live with type 2 diabetes, a condition commonly linked to obesity, in which badly regulated blood sugar levels can increase the risk of heart disease, kidney disease, strokes or nerve conditions. About 10,000 of them are being treated with weight-loss drugs such as Ozempic, Wegovy and Mounjaro, with injections costing the NHS £3,000 a year. The estimated annual bill of £30 million is expected to rise as manufacturers raise prices. NHS chiefs believe that not only will the soups and shakes plan be less expensive, it will also bring longer-term health benefits. In the Total Diet Replacement (TDR) plan, to be rolled out over three years, patients who have recently been diagnosed with type 2 diabetes and are deemed eligible will be given low-calorie substitutes for their breakfast, lunch and dinner. The replacement meals, containing a maximum of 900 calories a day, will be delivered to patients for between three and five months. • What to do now Mounjaro's hiking its prices, by an obesity expert After this initial period, normal food will be reintroduced, but with guidance given on healthy meals through online consultations and an app. The ambition is for patients to lose up to 10 per cent of their body weight over a year. Doctors are also optimistic that up to 40 per cent of the trial participants will achieve remission from type 2 diabetes within a year. There are fears that the weight lost through injections — which work by suppressing the appetite — may last only as long as the patient is taking the drug. By contrast, the effects of diet changes should prove more long-lasting and cost effective, NHS officials believe. The TDR scheme is set to cost £5.6 million for 3,000 patients, a one-off cost of about £1,866 per person. Doctors hope the plan will help patients to fundamentally alter their diet and lifestyle. A spokesman for the Scottish government said: 'We anticipate that around 35 to 40 per cent will achieve remission from type 2 diabetes at the end of their first year on the programme, with a majority of patients benefiting from a clinically significant average weight loss of 10 per cent.' This would lead to reductions in blood pressure and contribute to a reduced risk of cardiovascular disease. He added: 'We will measure impact by the number of patients recruited into this programme, the number who achieve remission and the number with clinically significant weight loss.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store